Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ATM polymorphisms as risk factors for prostate cancer development.

S Angèle1, A Falconer, S M Edwards

  • 1DNA Repair Group, International Agency for Research on Cancer, 150 cours Albert Thomas, 69373 Lyon, France.

British Journal of Cancer
|July 29, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional outcome of early weight bearing for acute Achilles tendon rupture treated conservatively in a weight-bearing orthosis.

Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons·2021
Same author

The Intensity-Modulated Pelvic Node and Bladder Radiotherapy (IMPART) Trial: A Phase II Single-Centre Prospective Study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Runs of homozygosity and testicular cancer risk.

Andrology·2019
Same author

Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Enantioselective total synthesis and biological evaluation of (-)-solanacol.

Organic & biomolecular chemistry·2018
Same author

Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer.

Psycho-oncology·2017

Germline mutations in DNA repair genes like BRCA2 increase prostate cancer risk. This study found a specific variant in the ATM gene (3161C>G) is associated with a higher risk of developing prostate cancer.

Area of Science:

  • Genetics and Cancer Biology
  • DNA Damage Response Pathways

Background:

  • Germline mutations in BRCA2, BRCA1, and CHEK2 are linked to increased prostate cancer risk.
  • These genes are involved in the ATM-dependent DNA damage signaling pathway.

Purpose of the Study:

  • To investigate the association between variants in the ATM gene and prostate cancer risk.
  • To determine if ATM gene variants contribute to prostate cancer susceptibility.

Main Methods:

  • Genotyping of five ATM variants in 637 prostate cancer patients and 445 cancer-free controls.
  • Analysis of allele frequencies and association with prostate cancer risk.
  • Cellular phenotype assessment of ATM variants after radiation exposure.

Main Results:

Related Experiment Videos

  • No significant association was found for four ATM variants (5557G>A, 5558A>T, ivs38-8t>c, ivs38-15g>c).
  • The ATM 3161G (P1054R) variant allele showed a significant association with increased prostate cancer risk (OR 2.13, P=0.016).
  • A cell line with homozygous ATM variants exhibited altered cell cycle progression post-irradiation compared to wild-type cells.

Conclusions:

  • Common variants in the ATM gene may alter cellular phenotype.
  • The ATM 3161C>G variant is potentially associated with an increased risk of prostate cancer.